GENETWORx was formed with patients as our central focus, translating the latest scientific findings into actionable knowledge and information for patients and their healthcare providers. We enable healthcare practitioners to provide targeted therapy to patients, based on their individual genetic profile.
21st-century technology has led to next-generation sequencers and mapping of the human genome. Several new fields have emerged from this technology including gene base therapy, and the advent of a branch of pharmacology driven by genetic testing: pharmacogenomics.
Pharmacogenomics is a science that examines the inherited variations in genes that dictate drug response. This science explores the ways these variations can be used to optimize drug therapy by assisting in drug selection, maximizing efficacy, and minimizing adverse effects.GENETWORx is a health management service company that specializes in bringing the benefits of genetic testing to the patient, via a network of healthcare providers who are knowledgeable about personalized medicine and pharmacogenomics.
Our core values:
The College of American Pathology (CAP) accreditation is the gold standard awarded to clinical laboratories that exceed inspection qualifications and ensures a consistent level of service that positively impacts patient care. GENETWORx is both CAP-accredited and certified according to the Clinical Laboratory Improvement Amendment (CLIA) for clinical processing of swab samples for genotyping of drug-metabolizing enzymes as well as bleeding risk factors. Achieving the CAP accreditation combined with the CLIA certification demonstrates GENETWORx’s unwavering commitment to patient care. Clinicians ordering our assays can have confidence that the results received are of the highest quality possible.
GENETWORx has met the Federal and State licensure requirements to operate in all 50 states.
- CAP Number: 8732425
- CLIA Number: 49D2060159